Cetera Advisors’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Cetera Advisors’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15,000	Closed	-$45K	–	993
2019 Q2	$45K	Hold	15,000	–	–	﹤0.01%	914
2019 Q1	$26K	Sell	15,000 -4,000	-21%	-$5.53K	﹤0.01%	1054
2018 Q4	$16K	Buy	19,000 +5,000	+36%	+$5.96K	﹤0.01%	834
2018 Q3	$19K	Hold	14,000	–	–	﹤0.01%	943
2018 Q2	$12K	Hold	14,000	–	–	﹤0.01%	863
2018 Q1	$19K	Buy	14,000 +1,000	+8%	+$1.16K	﹤0.01%	769
2017 Q4	$13K	Hold	13,000	–	–	﹤0.01%	771
2017 Q3	$20K	Hold	13,000	–	–	﹤0.01%	823
2017 Q2	$25K	Hold	13,000	–	–	﹤0.01%	806
2017 Q1	$17K	Hold	13,000	–	–	﹤0.01%	783
2016 Q4	$9K	Hold	13,000	–	–	﹤0.01%	720
2016 Q3	$14K	Buy	13,000 +1,000	+8%	+$1.34K	﹤0.01%	757
2016 Q2	$17K	Hold	12,000	–	–	﹤0.01%	763
2016 Q1	$12K	Buy	+12,000	New	+$20.6K	﹤0.01%	710

Other funds holding CVRS

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Cetera Advisors's CVRS Position: Q3 2019 in Review

Cetera Advisors sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q3 2019, closing a stake of 15,000 shares — an estimated $45K sold.

Cetera Advisors first reported a position in CVRS in Q1 2016 and held it in 14 quarters. The position peaked at $45K in Q2 2019. 101 funds tracked by Wall St. Rank hold CVRS as of Q3 2019.

Cetera Advisors reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q3 2019 after selling out during the quarter.
Cetera Advisors sold 15,000 CORINDUS VASCULAR ROBOTICS, INC shares in Q3 2019, an estimated $45K.
Cetera Advisors first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2016 and held it in 14 quarters.
Cetera Advisors's CORINDUS VASCULAR ROBOTICS, INC position peaked at $45K in Q2 2019.
101 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q3 2019.

Based on Cetera Advisors's 13F filing for Q3 2019, filed 6 Nov 2019.